| Authors: |
Makunts T; Oak Ridge Institute of Science and Education Fellowship at Office of Clinical Pharmacology, United States Food and Drug Administration, Silver Spring, MA, USA.; Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, CA, USA., Saunders IM; Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, CA, USA., Cohen IV; Clinical Pharmacology and Therapeutics (CPT) Postdoctoral Training Program, University of California San Francisco, San Francisco, CA, USA., Li M; Oak Ridge Institute of Science and Education Fellowship at Office of Clinical Pharmacology, United States Food and Drug Administration, Silver Spring, MA, USA., Moumedjian T; Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, CA, USA., Issa MA; Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, CA, USA., Burkhart K; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MA, USA., Lee P; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MA, USA., Patel SP; Center for Personalized Cancer Therapy, Division of Hematology and Medical Oncology, UCSD Moores Cancer Center, La Jolla, CA, USA., Abagyan R; Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, CA, USA. rabagyan@health.ucsd.edu. |
